Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 680615, 17 pages
http://dx.doi.org/10.1155/2015/680615
Research Article

Improvement of Endurance of DMD Animal Model Using Natural Polyphenols

1Laboratorio Cellule Staminali, Dipartimento di Patofisiologia e dei Trapianti, Universitá degli Studi di Milano, Fondazione IRCCS Cá Granda Ospedale Maggiore Policlinico, Centro Dino Ferrari, Via Francesco Sforza 35, 20122 Milano, Italy
2Sezione di Neuroscienze, Dipartimento di Patofisiologia e dei Trapianti, Universitá degli Studi di Milano, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Centro Dino Ferrari, Via Francesco Sforza 35, 20122 Milano, Italy
3Ystem S.r.l., Milano, Italy
4U.G.A. Nutraceuticals, Gubbio, Perugia, Italy

Received 30 May 2014; Revised 13 August 2014; Accepted 27 August 2014

Academic Editor: Giuseppe D’Antona

Copyright © 2015 Clementina Sitzia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. E. H. Emery, “The muscular dystrophies,” The Lancet, vol. 359, no. 9307, pp. 687–695, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Brunelli and P. Rovere-Querini, “The immune system and the repair of skeletal muscle,” Pharmacological Research, vol. 58, no. 2, pp. 117–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Jensen, E. Jebens, E. O. Brennesvik et al., “Muscle glycogen inharmoniously regulates glycogen synthase activity, glucose uptake, and proximal insulin signaling,” American Journal of Physiology—Endocrinology and Metabolism, vol. 290, no. 1, pp. E154–E162, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Xing, Y. Yu, and T. A. Rando, “The modulation of cellular susceptibility to oxidative stress: protective and destructive actions of Cu,Zn-superoxide dismutase,” Neurobiology of Disease, vol. 10, no. 3, pp. 234–246, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. G. Tidball and M. Wehling-Henricks, “Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo,” Journal of Physiology, vol. 578, no. 1, pp. 327–336, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. D. Howl and S. J. Publicover, “Permeabilisation of the sarcolemma in mouse diaphragm exposed to Bay K 8644 in vitro: time course, dependence on Ca2+ and effects of enzyme inhibitors,” Acta Neuropathologica, vol. 79, no. 4, pp. 438–443, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. T. A. Rando, “Oxidative stress and the pathogenesis of muscular dystrophies,” American Journal of Physical Medicine and Rehabilitation, vol. 81, no. 11, pp. S175–S186, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. N. P. Whitehead, E. W. Yeung, and D. G. Allen, “Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 7, pp. 657–662, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. M. A. Smith and M. B. Reid, “Redox modulation of contractile function in respiratory and limb skeletal muscle,” Respiratory Physiology and Neurobiology, vol. 151, no. 2-3, pp. 229–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Hauser, H. Hoger, R. Bittner, K. Widhalm, K. Herkner, and G. Lubec, “Oxyradical damage and mitochondrial enzyme activities in the mdx mouse,” Neuropediatrics, vol. 26, no. 5, pp. 260–262, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. J. W. Haycock, S. Mac Neil, P. Jones, J. B. Harris, and D. Mantle, “Oxidative damage to muscle protein in Duchenne muscular dystrophy,” NeuroReport, vol. 8, no. 1, pp. 357–361, 1997. View at Google Scholar · View at Scopus
  12. M. Canton, S. Menazza, and F. D. Lisa, “Oxidative stress in muscular dystrophy: From generic evidence to specific sources and targets,” Journal of Muscle Research and Cell Motility, vol. 35, no. 1, pp. 23–36, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. E. T. Chouchani, C. Methner, S. M. Nadtochiy et al., “Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I,” Nature Medicine, vol. 19, no. 6, pp. 753–759, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. H. S. Chung, S.-B. Wang, V. Venkatraman, C. I. Murray, and J. E. van Eyk, “Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system,” Circulation Research, vol. 112, no. 2, pp. 382–392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Eilat-Adar, T. Sinai, C. Yosefy, and Y. Henkin, “Nutritional recommendations for cardiovascular disease prevention,” Nutrients, vol. 5, no. 9, pp. 3646–3683, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. R. J. Fairclough, K. J. Perkins, and K. E. Davies, “Pharmacologically targeting the primary defect and downstream pathology in duchenne muscular dystrophy,” Current Gene Therapy, vol. 12, no. 3, pp. 206–244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Wang, O. K. Chun, and W. O. Song, “Plasma and dietary antioxidant status as cardiovascular disease risk factors: a review of human studies,” Nutrients, vol. 5, no. 8, pp. 2969–3004, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. R. Zatalia and H. Sanusi, “The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus,” Acta medica Indonesiana, vol. 45, no. 2, pp. 141–147, 2013. View at Google Scholar · View at Scopus
  19. T. Wallerath, G. Deckert, T. Ternes et al., “Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase,” Circulation, vol. 106, no. 13, pp. 1652–1658, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Nakae, O. M. Dorchies, P. J. Stoward, B. F. Zimmermann, C. Ritter, and U. T. Ruegg, “Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea,” Histochemistry and Cell Biology, vol. 137, no. 6, pp. 811–827, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Cabrera, R. Artacho, and R. Giménez, “Beneficial effects of green tea—a review,” The Journal of the American College of Nutrition, vol. 25, no. 2, pp. 79–99, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Bornman, H. Rossouw, G. S. Gericke, and B. S. Polla, “Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy,” Biochemical Pharmacology, vol. 56, no. 6, pp. 751–757, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. K. M. Fairfield and R. H. Fletcher, “Vitamins for chronic disease prevention in adults: scientific review,” Journal of the American Medical Association, vol. 287, no. 23, pp. 3116–3126, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. M. E. Murphy and J. P. Kehrer, “Oxidation state of tissue thiol groups and content of protein carbonyl groups in chickens with inherited muscular dystrophy,” Biochemical Journal, vol. 260, no. 2, pp. 359–364, 1989. View at Google Scholar · View at Scopus
  25. S. Messina, D. Altavilla, M. Aguennouz et al., “Lipid peroxidation inhibition blunts nuclear factor-κB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice,” The American Journal of Pathology, vol. 168, no. 3, pp. 918–926, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Hodgetts, H. Radley, M. Davies, and M. D. Grounds, “Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx mice,” Neuromuscular Disorders, vol. 16, no. 9-10, pp. 591–602, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Hnia, G. Hugon, F. Rivier, A. Masmoudi, J. Mercier, and D. Mornet, “Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient mdx mice,” The American Journal of Pathology, vol. 170, no. 2, pp. 633–643, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Kumar and A. M. Boriek, “Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy,” The FASEB Journal, vol. 17, no. 3, pp. 386–396, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Thaloor, K. J. Miller, J. Gephart, P. O. Mitchell, and G. K. Pavlath, “Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury,” The American Journal of Physiology: Cell Physiology, vol. 277, no. 2, pp. C320–C329, 1999. View at Google Scholar · View at Scopus
  30. K. Overvad, B. Diamant, L. Holm, G. Hølmer, S. A. Mortensen, and S. Stender, “Coenzyme Q10 in health and disease,” European Journal of Clinical Nutrition, vol. 53, no. 10, pp. 764–770, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. C. F. Spurney, T. R. Carolina, E. Henricson et al., “CINRG pilot trial of coenzyme Q10 in Steroid-Treated duchenne muscular dystrophy,” Muscle and Nerve, vol. 44, no. 2, pp. 174–178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. L. Flanagan, P. A. Simmons, J. Vehige, M. D. Willcox, and Q. Garrett, “Role of carnitine in disease,” Nutrition and Metabolism, vol. 7, article 30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Le Borgne, S. Guyot, M. Logerot, L. Beney, P. Gervais, and J. Demarquoy, “Exploration of lipid metabolism in relation with plasma membrane properties of Duchenne muscular dystrophy cells: influence of L-carnitine,” PLoS ONE, vol. 7, no. 11, Article ID e49346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Zolkipli, L. Mai, A. M. Lamhonwah, and I. Tein, “The mdx mouse as a model for carnitine deficiency in the pathogenesis of duchenne muscular dystrophy,” Muscle and Nerve, vol. 46, no. 5, pp. 767–772, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. L. A. Horrocks and Y. K. Yeo, “Health benefits of docosahexaenoic acid (DHA),” Pharmacological Research, vol. 40, no. 3, pp. 211–225, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Fogagnolo Mauricio, E. Minatel, H. Santo Neto, and M. J. Marques, “Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice,” Clinical Nutrition, vol. 32, no. 4, pp. 636–642, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. Z. Gao, K. Huang, X. Yang, and H. Xu, “Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1472, no. 3, pp. 643–650, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. X. Shang, X. He, M. Li et al., “The genus Scutellaria an ethnopharmacological and phytochemical review,” Journal of Ethnopharmacology, vol. 128, no. 2, pp. 279–313, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Palomero, D. Pye, T. Kabayo, and M. J. Jackson, “Effect of passive stretch on intracellular nitric oxide and superoxide activities in single skeletal muscle fibres: Influence of ageing,” Free Radical Research, vol. 46, no. 1, pp. 30–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. B. Reid, G. J. Grubwieser, D. S. Stokic, S. M. Koch, and A. A. Leis, “Development and reversal of fatigue in human tibialis anterior,” Muscle and Nerve, vol. 16, no. 11, pp. 1239–1245, 1993. View at Publisher · View at Google Scholar · View at Scopus
  41. M. B. Reid, “Nitric oxide, reactive oxygen species, and skeletal muscle contraction,” Medicine and Science in Sports and Exercise, vol. 33, no. 3, pp. 371–376, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. K. Powers and M. J. Jackson, “Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production,” Physiological Reviews, vol. 88, no. 4, pp. 1243–1276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. B. Reid, “Free radicals and muscle fatigue: Of ROS, canaries, and the IOC,” Free Radical Biology and Medicine, vol. 44, no. 2, pp. 169–179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Renjini, N. Gayathri, A. Nalini, and M. M. S. Bharath, “Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism,” Neurochemical Research, vol. 37, no. 4, pp. 885–898, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. J. T. Selsby, “Increased catalase expression improves muscle function in mdx mice,” Experimental Physiology, vol. 96, no. 2, pp. 194–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Davinelli, N. Sapere, M. Visentin, D. Zella, and G. Scapagnini, “Enhancement of mitochondrial biogenesis with polyphenols: combined effects of resveratrol and equol in human endothelial cells,” Immunity and Ageing, vol. 10, no. 1, article 28, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Wang, W. Bi, A. Cheng et al., “Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications,” Frontiers in Aging Neuroscience, vol. 6, article 42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Wang, S. Rousseaux, and S. Khochbin, “Sustaining cancer through addictive ectopic gene activation,” Current Opinion in Oncology, vol. 26, no. 1, pp. 73–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Brunelli, C. Sciorati, G. D'Antona et al., “Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 1, pp. 264–269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. N. P. Evans, S. A. Misyak, J. L. Robertson, J. Bassaganya-Riera, and R. W. Grange, “Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in duchenne muscular dystrophy,” American Journal of Physical Medicine & Rehabilitation, vol. 88, no. 6, pp. 502–522, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Vidal, A. L. Serrano, M. Tjwa et al., “Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway,” Genes and Development, vol. 22, no. 13, pp. 1747–1752, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Drapeau, D. Antarr, H. Ma et al., “Mobilization of bone marrow stem cells with StemEnhance improves muscle regeneration in cardiotoxin-induced muscle injury,” Cell Cycle, vol. 9, no. 9, pp. 1819–1823, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. G. S. Jensen, A. N. Hart, L. A. M. Zaske et al., “Mobilization of human CD34+CD133+ and CD34+CD133- stem cells in vivo by consumption of an extract from Aphanizomenon flos-aquae—related to modulation of CXCR4 expression by an L-selectin ligand?” Cardiovascular Revascularization Medicine, vol. 8, no. 3, pp. 189–202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. E. A. Sweeney, H. Lortat-Jacob, G. V. Priestley, B. Nakamoto, and T. Papayannopoulou, “Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: Involvement in mobilization of stem/progenitor cells,” Blood, vol. 99, no. 1, pp. 44–51, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. M. A. Goodell, K. A. Jackson, S. M. Majka et al., “Stem cell plasticity in muscle and bone marrow,” Annals of the New York Academy of Sciences, vol. 938, pp. 208–218, 2001, discussion 218–220. View at Google Scholar
  56. D. G. Allen and N. P. Whitehead, “Duchenne muscular dystrophy—what causes the increased membrane permeability in skeletal muscle?” International Journal of Biochemistry and Cell Biology, vol. 43, no. 3, pp. 290–294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. J. R. Terrill, H. G. Radley-Crabb, T. Iwasaki, F. A. Lemckert, P. G. Arthur, and M. D. Grounds, “Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies,” FEBS Journal, vol. 280, no. 17, pp. 4149–4164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. B. S. Gordon, D. C. Delgado Diaz, and M. C. Kostek, “Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of duchenne muscular dystrophy,” Clinical Nutrition, vol. 32, no. 1, pp. 104–111, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Lönnrot, P. Holm, A. Lagerstedt, H. Huhtala, and H. Alho, “The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations end life span of male rats and mice,” Biochemistry and Molecular Biology International, vol. 44, no. 4, pp. 727–737, 1998. View at Google Scholar · View at Scopus
  60. E. Gussoni, Y. Soneoka, C. D. Strickland et al., “Dystrophin expression in the mdx mouse restored by stem cell transplantation,” Nature, vol. 401, no. 6751, pp. 390–394, 1999. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Rosu-Myles, E. Stewart, J. Trowbridge, C. Y. Ito, P. Zandstra, and M. Bhatia, “A unique population of bone marrow cells migrates to skeletal muscle via hepatocyte growth factor/c-met axis,” Journal of Cell Science, vol. 118, no. 19, pp. 4343–4352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Asakura, “Skeletal muscle-derived hematopoietic stem cells: muscular dystrophy therapy by bone marrow transplantation,” Journal of Stem Cell Research & Therapy, supplement 11, 2012. View at Google Scholar
  63. S.-I. Fukada, Y. Miyagoe-Suzuki, H. Tsukihara et al., “Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fluorescent protein-gene transgenic mice,” Journal of Cell Science, vol. 115, no. 6, pp. 1285–1293, 2002. View at Google Scholar · View at Scopus
  64. L. Ding, T. L. Saunders, G. Enikolopov, and S. J. Morrison, “Endothelial and perivascular cells maintain haematopoietic stem cells,” Nature, vol. 481, no. 7382, pp. 457–462, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. E. Gussoni, R. R. Bennett, K. R. Muskiewicz et al., “Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation,” Journal of Clinical Investigation, vol. 110, no. 6, pp. 807–814, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. V. Nair, S. Das, A. Sharma, S. Sharma, J. Kaur, and D. K. Mishra, “Successful bone marrow transplantation in a patient with Diamond-Blackfan anemia with co-existing Duchenne muscular dystrophy: a case report,” Journal of Medical Case Reports, vol. 5, article 216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. D. S. Krause, N. D. Theise, M. I. Collector et al., “Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell,” Cell, vol. 105, no. 3, pp. 369–377, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. F. Quaini, K. Urbanek, A. P. Beltrami et al., “Chimerism of the transplanted heart,” The New England Journal of Medicine, vol. 346, no. 1, pp. 5–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. A. M. Leone, S. Rutella, G. Bonanno et al., “Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction,” International Journal of Cardiology, vol. 111, no. 2, pp. 202–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. J. D. Abbott, Y. Huang, D. Liu, R. Hickey, D. S. Krause, and F. J. Giordano, “Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury,” Circulation, vol. 110, no. 21, pp. 3300–3305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. E. Abdel-Salam, I. Ehsan Abdel-Meguid, R. Shatla, and S. S. Korraa, “Stromal cell-derived factors in Duchenne muscular dystrophy,” Acta Myologica, vol. 29, pp. 398–403, 2010. View at Google Scholar · View at Scopus
  72. B. de Paepe and J. L. de Bleecker, “Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy,” Mediators of Inflammation, vol. 2013, Article ID 540370, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. P. Anderlini, D. Przepiorka, R. Champlin, and M. Körbling, “Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals,” Blood, vol. 88, no. 8, pp. 2819–2825, 1996. View at Google Scholar · View at Scopus
  74. E. Brzoska, M. Kowalewska, A. Markowska-Zagrajek et al., “Sdf-1 (CXCL12) improves skeletal muscle regeneration via the mobilisation of Cxcr4 and CD34 expressing cells,” Biology of the Cell, vol. 104, no. 12, pp. 722–737, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. M. A. Kuliszewski, J. Kobulnik, J. R. Lindner, D. J. Stewart, and H. Leong-Poi, “Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle,” Molecular Therapy, vol. 19, no. 5, pp. 895–902, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. A. T. Palermo, M. A. LaBarge, R. Doyonnas, J. Pomerantz, and H. M. Blau, “Bone marrow contribution to skeletal muscle: a physiological response to stress,” Developmental Biology, vol. 279, no. 2, pp. 336–344, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Z. Ratajczak, M. Kucia, R. Reca, M. Majka, A. Janowska-Wieczorek, and J. Ratajczak, “Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells ‘hide out’ in the bone marrow,” Leukemia, vol. 18, no. 1, pp. 29–40, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Pignatelli, F. M. Pulcinelli, A. Celestini et al., “The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide,” The American Journal of Clinical Nutrition, vol. 72, no. 5, pp. 1150–1155, 2000. View at Google Scholar · View at Scopus
  79. R. Benchaouir, M. Meregalli, A. Farini et al., “Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice,” Cell Stem Cell, vol. 1, no. 6, pp. 646–657, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. F. S. Tedesco, M. F. M. Gerli, L. Perani et al., “Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy,” Science Translational Medicine, vol. 4, no. 140, Article ID 140ra89, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. F. S. Tedesco, H. Hoshiya, G. D'Antona et al., “Stem cell-mediated transfer of a human artificial chromosome ameliorates muscular dystrophy,” Science Translational Medicine, vol. 3, no. 96, Article ID 96ra78, 2011. View at Publisher · View at Google Scholar
  82. L. Benov, L. Sztejnberg, and I. Fridovich, “Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical,” Free Radical Biology and Medicine, vol. 25, no. 7, pp. 826–831, 1998. View at Publisher · View at Google Scholar · View at Scopus
  83. D. W. Porter, L. L. Millecchia, P. Willard et al., “Nitric oxide and reactive oxygen species production causes progressive damage in rats after cessation of silica inhalation,” Toxicological Sciences, vol. 90, no. 1, pp. 188–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. N. P. Whitehead, C. Pham, O. L. Gervasio, and D. G. Allen, “N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice,” Journal of Physiology, vol. 586, no. 7, pp. 2003–2014, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. N. Bresolin, M. Zeviani, E. Bonilla et al., “Fatal infantile cytochrome C oxidase deficiency: decrease of immunologically detectable enzyme in muscle,” Neurology, vol. 35, no. 6, pp. 802–812, 1985. View at Publisher · View at Google Scholar · View at Scopus